Indo Us Bio-Tech Limited (BOM:541304)
India · Delayed Price · Currency is INR 85.04
-1.02 (-1.19%)
At close: Aug 21, 2026
Indo Us Bio-Tech Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 1,127 | 1,104 | 1,038 | 728.36 | 617.45 | 500.59 |
Revenue Growth | 2.52% | 6.36% | 42.56% | 17.96% | 23.34% | 24.80% |
Gross Profit Gross Profit Growth | 284.82 | 301.69 | 339.95 | 261.97 | 183.5 | 157.08 |
Operating Income Operating Income Growth | 147.09 | 161.64 | 179.49 | 102.66 | 85.71 | 64.99 |
Net Income Net Income Growth | 114.58 | 131.23 | 162.67 | 82.41 | 72.4 | 50.63 |
Earnings Per Share EPS Growth | 5.70 | 6.54 | 8.11 | 4.11 | 3.75 | 4.13 |
EPS Growth | -35.86% | -19.38% | 97.41% | 9.49% | -9.22% | 22.97% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Agricultural Activities Agricultural Activities Growth | 765.6 | 679.66 | 527.97 | 444.82 |
Trading Activities Trading Activities Growth | 272.79 | 48.7 | 89.48 | 55.71 |
Total Total Growth | 1,038 | 728.36 | 617.45 | 500.53 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 61.23 | 61.23 | 2.48 | 10.98 | 1.9 | 0.49 |
Total Debt Total Debt Growth | 370.36 | 370.36 | 148.36 | 143.24 | 115.99 | 128.39 |
Net Cash (Debt) Net Cash Growth | -309.13 | -309.13 | -145.88 | -132.26 | -114.1 | -127.9 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -15.39 | -15.41 | -7.28 | -6.60 | -5.92 | -10.45 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | -125.81 | 14.19 | 22.21 | 5.26 | 27.03 |
Capital Expenditures CapEx Growth | - | -24.08 | -8.62 | -26.1 | -18.23 | -39.67 |
Free Cash Flow Free Cash Flow Growth | - | -149.89 | 5.57 | -3.89 | -12.97 | -12.64 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 25.28% | 27.32% | 32.74% | 35.97% | 29.72% | 31.38% |
Operating Margin | 13.06% | 14.64% | 17.29% | 14.09% | 13.88% | 12.98% |
Pretax Margin | 10.81% | 12.60% | 15.92% | 12.07% | 11.96% | 10.61% |
Profit Margin | 10.17% | 11.88% | 15.67% | 11.31% | 11.73% | 10.12% |
FCF Margin | - | -13.57% | 0.54% | -0.53% | -2.10% | -2.52% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.250 | - | - | 0.125 |
Dividend Per Share Growth | - | - | - | - |
Dividend Yield | 0.17% | - | - | 0.37% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 14.91 | 14.96 | 18.15 | 54.01 | 29.43 | 12.22 |
P/FCF Ratio | - | - | 529.88 | - | - | - |
PS Ratio | 1.51 | 1.78 | 2.84 | 6.11 | 3.45 | 1.24 |